Evogene Ltd. (EVGN) Estados Financieros e Histórico

Evogene Ltd. (EVGN) — Precio $0.50 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Evogene Ltd. (EVGN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Evogene Ltd. registró ingresos de $3.9M en el último ejercicio fiscal, con un CAGR de 5 años del 29.9%.

Márgenes de los últimos 12 meses: margen bruto -14.2%, margen operativo -10.2%, margen neto -7.0%.

Al precio actual de $0.50, EVGN presenta beneficios negativos (P/E no significativo) y un ROE del 7.66%. La capitalización bursátil es de $4M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$6.5M$3.4M$1.7M$753000$1.0M$930000$1.7M$3.0M$5.6M$3.9M
Coste de Ventas$5.6M$2.8M$1.5M$334000$574000$767000$909000$1.5M$2.4M$4.1M
Beneficio Bruto$901000$536000$295000$419000$466000$163000$766000$1.5M$3.2M-$241000
I+D$16.4M$17.0M$14.7M$15.8M$17.3M$21.1M$20.8M$16.2M$12.5M$8.0M
Generales y Administrativos$5.6M$5.5M$5.6M$5.8M$8.0M$10.0M$10.4M$7.5M$9.0M$5.8M
Gastos Operativos$22.0M$22.5M$20.3M$21.6M$25.3M$31.1M$27.7M$23.7M$22.0M$13.8M
Beneficio Operativo-$21.1M-$21.9M-$20.0M-$21.2M-$24.8M-$31.0M-$26.9M-$22.2M-$18.8M-$14.0M
EBITDA-$18.8M-$18.7M-$18.8M-$16.0M-$23.2M-$27.9M-$27.0M-$20.5M-$13.4M-$12.2M
Gastos por Intereses$155000$129000$141000$354000$269000$403000$241000$171000$124000$1.9M
Beneficio Antes de Impuestos-$19.6M-$20.8M-$20.8M-$19.1M-$26.2M-$30.4M-$29.8M-$21.9M-$14.8M-$13.5M
Impuestos$36000$11000$30000$24000$32000$13000$90000$19000$9000$1000
Beneficio Neto-$19.6M-$20.8M-$20.8M-$18.1M-$23.4M-$27.8M-$26.6M-$23.9M-$16.5M-$8.5M
BPA$-0.77$-0.81$-0.81$-0.70$-0.64$-0.68$-6.46$-5.23$-2.89$-1.08
BPA Diluido$-0.77$-0.81$-0.81$-0.70$-0.64$-0.68$-6.46$-5.23$-2.89$-1.08
Acciones en Circulación (Diluidas)$25.4M$25.7M$25.8M$25.8M$36.6M$41.0M$4.1M$4.6M$5.7M$7.9M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$312000$314000$334000$347000
Beneficio Bruto$155000-$2.0M$204000-$8000
Beneficio Operativo-$2.7M-$5.2M-$3.1M-$2.4M
EBITDA-$2.0M-$6.5M-$1.8M-$2.3M
Beneficio Neto$3.9M-$5.3M-$5.9M-$1.8M
BPA$0.44$-0.61$-0.60$-0.14
BPA Diluido$0.44$-0.61$-0.60$-0.14

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$3.2M$3.4M$5.8M$34.7M$46.2M$32.3M$29.0M$20.8M$15.3M$13.0M
Inversiones a Corto$84.9M$68.3M$48.7M$12.1M$2.0M$21.5M$6.4M$10.3M$100000
Cuentas por Cobrar$1.2M$813000$746000$1.2M$2.2M$1.2M$803000$804000$1.5M$1.4M
Inventario00000$92000$566000$76000$1.8M$210000
Activos Corrientes$89.5M$72.8M$55.5M$49.0M$51.8M$56.9M$37.8M$34.5M$21.6M$15.6M
Inmovilizado Material$6.5M$4.8M$3.2M$5.3M$3.9M$4.2M$4.1M$3.4M$4.3M$2.6M
Fondo de Comercio0000000000
Activos Intangibles000$17.1M$16.1M$15.2M$14.1M$13.2M$12.2M0
Activos Totales$96.0M$77.6M$58.7M$71.4M$71.9M$76.3M$56.1M$51.1M$39.9M$20.0M
Cuentas por Pagar$1.3M$1.1M$1.0M$1.0M$863000$1.5M$1.0M$1.8M$1.2M$639000
Deuda a Corto00000000$10.4M0
Pasivos Corrientes$5.2M$4.7M$5.4M$5.7M$9.7M$6.9M$5.6M$6.9M$18.7M$3.4M
Deuda a Largo000000$10.1M$10.4M00
Pasivos Totales$8.7M$8.2M$8.4M$11.1M$15.0M$12.9M$21.3M$22.4M$25.0M$8.1M
Reservas-$96.2M-$117.0M-$137.8M-$155.9M-$179.3M-$207.1M-$233.7M-$257.6M-$274.1M-$282.6M
Patrimonio Neto$87.3M$69.4M$50.1M$50.1M$46.0M$53.7M$27.9M$12.1M-$1.5M-$82000
Deuda Total000$3.0M$2.4M$2.7M$11.9M$11.5M$12.9M$2.2M
Deuda Neta-$88.1M-$71.8M-$54.5M-$43.9M-$45.8M-$51.2M-$23.4M-$19.6M-$2.4M-$10.8M
Capital Circulante$84.3M$68.1M$50.1M$43.3M$42.1M$50.0M$32.1M$27.5M$2.9M$12.2M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$5.6M$13.0M$8.5M$9.4M
Activos Totales$26.1M$20.0M$17.9M$13.4M
Pasivos Totales$8.8M$8.1M$10.0M$7.7M
Patrimonio Neto$1.1M-$82000-$2.5M-$3.3M
Deuda Total$2.5M$2.2M$2.0M$2.1M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$19.6M-$20.8M-$20.8M-$19.1M-$26.2M-$30.4M-$29.8M-$26.0M-$18.1M-$14.2M
Amortizaciones$2.3M$2.1M$2.0M$2.8M$2.7M$2.2M$2.6M$2.6M$2.5M$1.1M
Compensación en Acciones$2.9M$2.2M$1.7M$1.6M$4.1M$2.6M$1.2M$1.9M$1.8M$654000
Cambio en Capital Circulante$1.9M-$196000-$161000-$997000-$1.4M$1.7M-$771000-$400000-$3.3M-$1.3M
Flujo de Caja Operativo-$11.7M-$15.9M-$15.2M-$17.4M-$19.5M-$24.8M-$23.7M-$21.6M-$19.7M-$13.5M
Inversiones (CapEx)-$808000-$590000-$374000-$900000-$682000-$724000-$1.2M-$785000-$626000-$135000
Adquisiciones-$5.5M-$4.8M0$10.0M00000$78000
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$12.5M-$16.5M-$15.5M-$18.3M-$20.2M-$25.6M-$24.8M-$22.4M-$20.3M-$13.6M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$3.8M-$2.7M-$3.0M-$2.1M
Inversiones (CapEx)-$11372-$6000-$2000-$9287
Flujo de Caja Libre-$3.8M-$2.7M-$3.0M-$2.1M
Dividendos Pagados00-$192999-$2.5M
Compensación en Acciones0$15500000

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)-48.3%-48.3%-56.9%+38.1%-10.6%+80.1%+78.0%+87.0%-30.9%
Crecimiento Beneficio Neto (anual)-6.4%+0.4%+12.7%-29.1%-18.9%+4.2%+10.4%+31.0%+48.5%
Crecimiento BPA (anual)-5.2%+0.0%+13.6%+8.6%-6.3%-850.0%+19.0%+44.7%+62.6%
Cambio en Acciones (anual)+1.1%+0.1%+0.0%+41.9%+12.2%-90.0%+10.9%+24.7%+38.2%
Crecimiento FCF (anual)-32.1%+6.0%-17.6%-10.6%-26.6%+2.8%+10.0%+9.1%+32.9%
Margen Bruto13.8%15.9%16.9%55.6%44.8%17.5%45.7%50.0%57.3%-6.3%
Margen Operativo-322.5%-649.1%-1144.2%-2810.9%-2386.0%-3328.3%-1608.4%-745.5%-337.2%-364.2%
Margen EBITDA-287.6%-552.6%-1074.0%-2127.5%-2231.7%-2998.2%-1612.5%-688.5%-239.6%-316.6%
Margen Neto-299.6%-616.3%-1188.2%-2405.3%-2247.5%-2988.5%-1590.3%-800.8%-295.6%-220.2%
Margen FCF-191.1%-488.6%-889.2%-2425.5%-1941.9%-2748.7%-1483.5%-749.9%-364.5%-353.9%
Tasa Impositiva Efectiva-0.2%-0.1%-0.1%-0.1%-0.1%-0.0%-0.3%-0.1%-0.1%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-0.49$-0.64$-0.60$-0.71$-0.55$-0.62$-6.03$-4.89$-3.57$-1.73
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$25.4M$25.7M$25.8M$25.8M$36.6M$41.0M$4.1M$4.6M$5.7M$7.9M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital766.01%
Rentabilidad sobre capital invertido-121.41%
Rentabilidad sobre activos-68.20%
Margen bruto-14.16%
Margen operativo-1020.35%
Margen neto-696.26%

Salud financiera

Deuda / Patrimonio-0.64
Ratio corriente3.57
Piotroski F-Score2
Altman Z-Score-20.48

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-66.23-42.84-24.44-21.71-73.44-24.12-1.08-1.61-0.65-1.02
P/VC14.8712.8710.197.8137.3112.541.033.18-7.34-105.63
P/V198.42264.03291.88519.871651.98723.2517.2212.871.912.25
Margen Bruto13.8%15.9%16.9%55.6%44.8%17.5%45.7%50.0%57.3%-6.3%
Margen Operativo-322.5%-649.1%-1144.2%-2810.9%-2386.0%-3328.3%-1608.4%-745.5%-337.2%-364.2%
Margen Neto-299.6%-616.3%-1188.2%-2405.3%-2247.5%-2988.5%-1590.3%-800.8%-295.6%-220.2%

Empresas relacionadas: AEON · BOLT · CING · CLRB · COCP · DWTX · GLTO

Explorar sector: Healthcare · Biotechnology

Más secciones de EVGN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones